Browsing Tag
CELSCI
1 post
CEL-SCI’s Lead Head & Neck Cancer Candidate Shows 43% Survival Extension – CEL-SCI (AMEX:CVM)
CEL-SCI Corporation CVM reported new data from its pivotal Phase 3 study of Multikine (Leukocyte Interleukin) in newly diagnosed locally…
09/03/2023